IP Library › Granted Patent US 11,033,658
Granted Patent B2
US 11,033,658 · App. 16/459,907 · Granted Jun 15, 2021

Interpenetrating networks with covalent and ionic crosslinks

Inventors: Jeong-Yun Sun (Cambridge, MA); Xuanhe Zhao (Durham, NC); Widusha R. K. Illeperuma (Cambridge, MA); Kyu H. Oh (Seocho-gu, KR); Joost J. Vlassak (Lexington, MA); Zhigang Suo (Lexington, MA); Jianyu Li (Cambridge, MA); David J. Mooney (Sudbury, MA)
Assignee: President and Fellows of Harvard College
A61L27/52A61L27/16A61L27/20A61L27/26A61L27/48A61L27/50A61L27/60C08J3/075C08J3/246C08L5/04C08L33/26C08L71/02C08J2333/26C08J2405/04C08L2201/54C08L2203/02C08L2205/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,033,658
App. No.
16/459,907
Granted
Jun 15, 2021
Kind
B2
Abstract

The invention features a composition comprising a self-healing interpenetrating network hydrogel comprising a first network and a second network. The first network comprises covalent crosslinks and the second network comprises ionic or physical crosslinks. For example, the first network comprises a polyacrylamide polymer and second network comprises an alginate polymer.

Claims (18)

1. An interpenetrating networks hydrogel comprising a first network and a second network, wherein:

the first network comprises a covalently crosslinked polymer selected from the group consisting of polyacrylamide, poly(vinyl alcohol), poly(ethylene oxide) and its copolymers, polyethylene glycol (PEG), methacrylated PEG, and polyphosphazene; and

the second network comprises an ionically crosslinked polymer selected from the group consisting of alginate, chitosan, and agarose; wherein the first network and the second network are covalently coupled;

wherein the hydrogel has a Young's modulus value of at least 300 kPa.

2. The hydrogel of claim 1 , wherein the first network comprises polyacrylamide or polyethylene glycol (PEG) and wherein the second network comprises alginate.

3. The hydrogel of claim 1 , wherein the first network comprises a covalent crosslinking agent is selected from the group consisting of N,N-methylenebisacrylamide (MBAA), a methacrylate crosslinker, N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (ECC), N-hydroxysuccinimide, N-hydroxysulfosuccinimide, glutaraldehyde, and a transglutaminase.

4. The hydrogel of claim 1 , wherein the hydrogel has a fracture toughness value of at least 10 J/m 2 .

5. The hydrogel of claim 1 , wherein the hydrogel has a stretch value (λ) of from 2 to 25.

6. The hydrogel of claim 1 , wherein the second network comprises an ionic crosslinking agent is selected from the group consisting of CaCl 2 , CaSO 4 , CaCO 3 , hyaluronic acid, and polylysine.

7. An interpenetrating networks hydrogel comprising a first network and a second network, wherein:

the first network comprises a covalently crosslinked polymer selected from the group consisting of polyacrylamide, poly(vinyl alcohol), poly(ethylene oxide) and its copolymers, polyethylene glycol (PEG), methacrylated PEG, and polyphosphazene; and

the second network comprises an ionically crosslinked polymer selected from the group consisting of alginate, chitosan, and agarose; and

the hydrogel has a covalently crosslinked polymer/(covalently crosslinked polymer and ionically crosslinked polymer) ratio of between about 66.67 wt. % and 94.12 wt. % based on monomer weights, wherein the first network and the second network are covalently coupled.

8. The hydrogel of claim 7 , wherein the first network comprises polyacrylamide or polyethylene glycol (PEG) and wherein the second network comprises alginate.

9. The hydrogel of claim 7 , wherein the first network comprises a covalent crosslinking agent selected from the group consisting of N,N-methylenebisacrylamide (MBAA), a methacrylate crosslinker, N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (ECC), N-hydroxysuccinimide, N-hydroxysulfosuccinimide, glutaraldehyde, and a transglutaminase.

10. The hydrogel of claim 7 , wherein the second network comprises an ionic crosslinking agent selected from the group consisting of CaCl 2 , CaSO 4 , CaCO 3 , hyaluronic acid, and polylysine.

11. The hydrogel of claim 7 , wherein the first network comprises a covalent crosslinking agent that is N,N-methylenebisacrylamide (MBAA) and the second network comprises an ionic crosslinking agent that is CaSO 4 .

12. The hydrogel of claim 7 , wherein the hydrogel has a covalently crosslinked polymer/(covalently crosslinked polymer and ionically crosslinked polymer) ratio of between about 80 wt. % and 92.31 wt. % based on monomer weights.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2019
From: OH, KYU HWAN
To: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Reel/Frame 050162/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2019
From: ILLEPERUMA, WIDUSHA; LI, JIANYU; MOONEY, DAVID J.; SUN, JEONG-YUN; SUO, ZHIGANG; VLASSAK, JOOST J.; ZHAO, XUANHE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 050163/0200 →
Continuity (5)
Continuation 15172549 · Jun 3, 2016
Continuation 14370451
Provisional Application 61694039 · Aug 28, 2012
Provisional Application 61583586 · Jan 5, 2012
Related Publication 20200000967A1 · Jan 2, 2020
Cited By (1)
US 12,605,480